⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IRWD News
Ironwood Pharmaceuticals, Inc. - Class A
Form 8-K
sec.gov
IRWD
Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference
businesswire.com
IRWD
Form 8-K
sec.gov
IRWD
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Results; Achieves 2025 Financial Guidance and Reiterates Strong 2026 Outlook
businesswire.com
IRWD
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Investor Update Call
businesswire.com
IRWD
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Investor Update Call
businesswire.com
IRWD
Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance
businesswire.com
IRWD
Marquis Who's Who Honors Gerdus "Gus" Byleveld for Leadership in Technology and Software
accessnewswire.com
IRWD
Short Bowel Syndrome Market to Register Stunning Growth at a CAGR of 5% During the Forecast Period (2025-2034) Owing to the Launch of Novel GLP-2 Analogues | DelveInsight
prnewswire.com
IRWD
ZPH
TAK
JAGX
Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance
businesswire.com
IRWD